Projecten per jaar
Persoonlijk profiel
Expertise
Currently, i'm employed as a PhD-Candidate at the "Laboratory for Molecular and Cellular Therapy" (LMCT) researchgroup at the Vrije Universiteit Brussel. My work entails a jointproject between the LMCT and the "in Vivo Cellular and Molecular Imaging" (ICMI) researchgroups in which I’m investigating the immunogenic properties of targeted radionuclide therapy (TRT) mediated by single domain antibodies (sdAb’s).
Vingerafdruk
Verdiep u in de onderzoeksgebieden waarop Thomas Ertveldt actief is. Deze onderwerplabels komen uit het werk van deze persoon. Samen vormen ze een unieke vingerafdruk.
- 1 Soortgelijke profielen
Netwerk
Recente externe samenwerking op landen-/regioniveau. Duik in de details door op de stippen te klikken of
Projecten
- 1 Afgelopen
-
Emerging applications of nanobodies in cancer therapy
Awad, R. M., Meeus, F., Ceuppens, H., Ertveldt, T., Hanssens, H., Lecocq, Q., Mateusiak, L., Zeven, K., Valenta, H., De Groof, T. W. M., De Vlaeminck, Y., Krasniqi, A., De Veirman, K., Goyvaerts, C., D'Huyvetter, M., Hernot, S., Devoogdt, N. & Breckpot, K., 2022, In: International review of cell and molecular biology. 369, blz. 143-199 57 blz.Onderzoeksoutput: Article › peer review
Bestand1 Citaat (Scopus)54 Downloads (Pure) -
Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model
Ertveldt, T., De Beck, L., De Ridder, K., Locy, H., De Mey, W., Goyvaerts, C., Lecocq, Q., Ceuppens, H., De Vlaeminck, Y., Awad, R. M., Keyaerts, M., Devoogdt, N., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., jul 2022, In: Molecular Cancer Therapeutics. 21, 7, blz. 1136-1148 13 blz.Onderzoeksoutput: Article › peer review
Open Access -
TNF-alpha-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy
De Ridder, K., Locy, H., Piccioni, E., Zuazo, M. I., Awad, R. M., Verhulst, S., Van Bulck, M., De Vlaeminck, Y., Lecocq, Q., Reijmen, E., De Mey, W., De Beck, L., Ertveldt, T., Pintelon, I., Timmermans, J-P., Escors, D., Keyaerts, M., Breckpot, K. & Goyvaerts, C., 14 apr 2022, In: Frontiers in Immunology. 13, 15 blz., 811867.Onderzoeksoutput: Article › peer review
Open AccessBestand2 Citaten (Scopus)13 Downloads (Pure) -
CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma
De Veirman, K., Puttemans, J., Krasniqi, A., Ertveldt, T., Hanssens, H., Romao, E., Hose, D., Goyvaert, C., Vlummens, P., Muyldermans, S., Breckpot, K., Bruchertseifer, F., Morgenstern, A., D'Huyvetter, M. & Devoogdt, N., 2021, In: Oncoimmunology. 10, 1, 11 blz., 2000699.Onderzoeksoutput: Article › peer review
Open Access5 Citaten (Scopus) -
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer
Lecocq, Q., Debie, P., Puttemans, J., Awad, R. M., De Beck, L., Ertveldt, T., De Vlaeminck, Y., Goyvaerts, C., Raes, G., Keyaerts, M., Breckpot, K. & Devoogdt, N., 2 nov 2021, In: EJNMMI Research. 11, 1, 13 blz., 115.Onderzoeksoutput: Article › peer review
Open AccessBestand2 Citaten (Scopus)90 Downloads (Pure)
-
Nanobody-mediated molecular imaging provides spatiotemporal insight in mRNA-vaccine-induced PD-L1 upregulation
Thomas Ertveldt (Speaker), Sofie Meulewaeter (Speaker), Ine Lentacker (Contributor), Rein Verbeke (Contributor), Stefaan De Smedt (Contributor), Oscar Javier Olarte Rodriguez (Contributor), Kurt Barbé (Contributor), Nick Devoogdt (Contributor), Marleen Keyaerts (Contributor), Heleen Dewitte (Contributor) & Karine Breckpot (Contributor)
19 apr 2021Activiteit: Talk or presentation at a workshop/seminar
-
Noninvasive imaging and inhibition of human programmed death ligand 1 (PD-L1) using nanobody K2 to improve cancer immunotherapy
Robin Maximilian Awad (Contributor), Dora Mugoli Chigoho (Contributor), Katrijn Broos (Contributor), Quentin Lecocq (Contributor), Katty Zeven (Contributor), Thomas Ertveldt (Contributor), Lien De Beck (Contributor), Hannelore Ceuppens (Contributor), Yannick De Vlaeminck (Contributor), Cleo Goyvaerts (Contributor), Steve Schoonooghe (Contributor), Vicky Caveliers (Contributor), Catarina Xavier (Contributor), Jessica Bridoux (Contributor), Geert Raes (Contributor), Marleen Keyaerts (Contributor), Nick Devoogdt (Contributor) & Karine Breckpot (Speaker)
25 okt 2021 → 26 okt 2021Activiteit: Talk or presentation at a conference
Bestand
Scriptie
-
Immunogenic effect of targeted radionuclide therapy-induced tumor cell death
Auteur: Ertveldt, T., Breckpot, K., Keyaerts, M., D'Huyvetter, M. & Krasniqi, A., 15 jun 2019Begeleider: Krasniqi, A. (Promotor)
Scriptie/Masterproef: Master's Thesis